Travere Therapeutics (NASDAQ:TVTX) Rating Increased to Neutr

Bryan, Garnier & Co upgraded shares of Travere Therapeutics (NASDAQ:TVTX – Get Rating) from a sell rating to a neutral rating in a research report released on Friday, Briefing.com reports. Several other research firms have also issued reports on TVTX. Piper Sandler lowered their target price on shares of Travere Therapeutics from $44.00 to $41.00 […]

Related Keywords

San Diego , California , United States , New York , Piper Sandler , Zurcher Kantonalbank Zurich Cantonalbank , Barclays , Mirae Asset Global Investments Co , York Life Investment Management , Travere Therapeutics Inc , Canaccord Genuity Group , Barclays Plc , Monashee Investment Management , Garnier Co , Travere Therapeutics , Get Rating , Genuity Group , Moderate Buy , Kantonalbank Zurich Cantonalbank , Investment Management , Mirae Asset Global Investments , Asset Global Investments , Martin Shkreli , Travere Therapeutics Daily , Nasdaq Tvtx , Tvtx , Medical , Upgrade , Bryan Garnier Co ,